ArticleBioinformatics advances2026
Interpretable prediction and generation of ASC-speck aptamers using multiscale deep biological learning models.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Aptamers are functional nucleic acids that can bind to corresponding ligands and effectively replace monoclonal antibodies. However, some target proteins may lack binding candidate DNA sequence, necessitating methods to generate new aptamer libraries for out-of-donor detection. Therefore, we propose an adaptive prediction and design method, ASC2BF for DNA aptamer generation. Results: Based on the multiscale residual network, ASC2BF not only predicts the aptamers simultaneously based on the characteristics of DNA-protein aptamers, but also uses the bacterial foraging optimization algorithm (BFOA) to generate new DNA aptamer sequences based on biophysical constraints, with initial seeds screened by the neural network predictor. As a case study, ASC2BF was applied to generate aptamer pools against apoptosis-associated speck-like proteins (ASC-speck). Furthermore, we demonstrate the ability of deep learning to capture sequential and functional semantic information. And through interpretability analysis, our results demonstrate what the model learns, helping us build a map from discovering important information to analyzing its biological function. Availability and implementation: The code and data sets are obtainable at https://github.com/nmt315320/aptamer.git.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.